Thesis - Open Access
Master of Science (MS)
Chemistry and Biochemistry
Fathi T. Halaweish
click chemistry, colerectal cancer, docking, EGFR, estradiols, triazole
Colorectal cancer is a life threatening and second cause of death from cancer in the United States. Several proteins (molecular targets) are highly expressed in Colorectal cancer (CRC). Among these molecular targets is Epidermal Growth Factor Receptors (EGFRs) which are overexpressed in cancer cells. Targeting and blocking the downstream signaling could lead to cease cell proliferation and division and hence control the spread of the disease. Molecular modeling is a powerful tool in drug discovery, which has been utilized to design many drug candidates that exhibit biological effect in many disease including cancer. Additionally, pharmacophores such as 1,2,3-triazole showed potency towards many diseases including cancer. Therefore, incorporation of 1,2,3-triazole on a carrier such as estradiol could lead to novel analogs in drug discovery for treatment of cancer. A library of 800 compound containing 1,2,3-triazole-estradiol analogs were designed and virtually screened with seven molecular targets belong to EGFRs utilizing OpenEye® software. Among the designed candidates, fourteen of estradiol-triazole analogs were synthesized and biologically evaluated. Antiproliferation/cytotoxicity assay conducted on CRC cancer cell line (HT-29) showed that 5 out 14 analogs demonstrated potential antiproliferation activities ranging from 3.5 μM to 30 μM in comparison to a chemotherapeutic agent 5- flurouracil (5-FU) (IC50 17.3 μM) which is a standard drug for CRC.
Includes bibliographical references
Number of Pages
South Dakota State University
Copyright © 2017 Faez Suhail Alotaibi
Alotaibi, Faez, "Design, Synthesis and Biological Evaluation of Novel Estradiol-Triazole Analogs Targeting Epidermal Growth Factor Receptors in Colorectal Cancer" (2017). Theses and Dissertations. 1189.